Few price levels command as much psychological weight as $100. For Cameco Corporation (CCJ), the world's second-largest uranium producer, the round-number threshold has become a focal point for investors after the stock tumbled from its January 2026 all-time high of $134.09 to its current level near $87.86. The question "Should You Buy Cameco While It's Below $100?" has circulated widely across financial media, reflecting genuine investor uncertainty about whether the nuclear trade still has room to run. A move back to $100 would represent a recovery of roughly 14% from current levels — meaningful but not extraordinary for a stock that surged more than 160% over the prior three years.
Cameco, headquartered in Saskatoon, Saskatchewan, mined approximately 15% of the world's uranium in 2025, ranking second only to Kazakhstan's state-run Kazatomprom. The company operates tier-one assets including the high-grade Cigar Lake and McArthur River mines in Canada. Beyond mining, Cameco has strategically diversified through its 49% stake in Westinghouse Electric, acquired in partnership with BAM (Brookfield Asset Management) in 2023. Westinghouse is one of the world's leading nuclear reactor technology and services companies, and this investment transformed Cameco from a pure-play commodity miner into a vertically integrated nuclear energy company with exposure across the entire fuel cycle — from uranium extraction through reactor design and maintenance.
Cameco shares have endured a sharp correction, falling 18% in the past month and 27% over six months. The sell-off has been attributed broadly to shifting AI-related market sentiment rather than deterioration in the company's underlying fundamentals, according to a July 27 UBS upgrade note. The stock's 52-week range spans from $68.96 to $135.24, and the recent pullback places CCJ closer to the lower end of that spectrum. With a market capitalization near $38 billion and a trailing P/E ratio above 80, Cameco trades at multiples more reminiscent of a high-growth technology company than a traditional mining operation — a reflection of the market's elevated long-term expectations for nuclear energy.
Several powerful catalysts support the case for a return to $100. First, long-term uranium contract prices have reached record highs, driven by utility companies scrambling to secure supply amid growing recognition of an impending uranium deficit. Citi analysts have projected spot uranium could reach $100–$125 per pound, up from roughly $84 at the end of March 2026.
Second, the U.S. government partnership announced in late 2025 — a framework to deploy at least $80 billion in new Westinghouse reactors — represents a generational demand signal. The Department of Energy has conditionally committed up to $17.5 billion in loan support to accelerate AP1000 reactor deployment, potentially shortening project timelines by three years.
Third, Cameco's Westinghouse stake provides a revenue stabilizer that pure-play miners lack. In the first nine months of 2025, Cameco's share of Westinghouse adjusted EBITDA surged 78% year-over-year to $569 million. Finally, UBS on July 27 upgraded CCJ to Buy from Neutral with a C$166 price target, arguing that the recent sell-off was sentiment-driven and that the nuclear cycle remains in its early stages with demand growth exceeding 3.5% annually.
Despite the compelling long-term narrative, near-term headwinds are real. The stock's premium valuation leaves it vulnerable — a P/E above 80 means any earnings disappointment can trigger outsized price reactions. Cameco's third-quarter 2025 earnings per share of $0.07 missed consensus estimates of $0.23 by a wide margin, reminding investors that operational lumpiness is inherent in the uranium business.
Additionally, the Westinghouse partnership's revenue benefits remain conditional. The DOE loan commitment is significant, but converting government backing into durable, visible revenue streams will take years, not months. There is also execution risk: Orano's McClean Lake mill, which processes ore from Cameco's Cigar Lake mine, faced operational issues requiring a temporary suspension, highlighting the supply-chain vulnerabilities that persist across the nuclear fuel cycle.
Wall Street remains overwhelmingly constructive. According to consensus data, 25 analysts rate CCJ a consensus "Buy," with an average 12-month price target near $131. The lowest target among major firms is $102 from Barclays, who initiated coverage with an Equal-Weight rating in May 2026. RBC Capital maintains an Outperform rating with a $175 target, while BofA holds at Buy with a $140 target. Notably, even the most conservative analyst projections sit above $100, suggesting that professional forecasters consider a return to triple digits as a baseline scenario rather than an aspirational stretch.
From a technical perspective, $100 serves as both a psychological round number and a prior support-turned-resistance zone. The stock traded near this level extensively in late 2025 before surging to its all-time high. On the downside, the $85 area — roughly where shares found support in recent weeks — represents the first line of defense. Below that, the 52-week low of $68.96 marks a critical support zone that has held through multiple pullbacks. A sustained move above $100 would likely require the stock to clear the $106–$110 range, where selling pressure emerged during the decline from January highs.
Navigating price swings in names like Cameco requires timely, data-driven insight. Tickeron's AI Daily Buy/Sell Signals leverage artificial intelligence to continuously monitor thousands of stocks and ETFs, generating actionable Buy, Sell, or Hold recommendations based on evolving market conditions, technical patterns, and AI-powered analysis. Traders can use these signals to screen for fresh opportunities, track existing positions with greater confidence, and detect shifts in market momentum before they become obvious. For those watching whether CCJ can reclaim $100, the platform offers an efficient way to stay ahead of changing conditions.
The question of whether Cameco can reach $100 is not about if the business can support that valuation — it already did, and analyst models unanimously project it will again. The more relevant question is timing and pathway. The nuclear renaissance thesis remains intact: AI-driven electricity demand, government policy support, and a tightening uranium supply market create a structurally bullish backdrop. The recent pullback appears driven by broader market rotation rather than fundamental deterioration, which is precisely why UBS chose this moment to upgrade the stock.
That said, a high P/E multiple leaves no margin for error. Progress on Westinghouse reactor contracts, sustained uranium price strength above $80 per pound, and clean operational execution will all be necessary to rebuild momentum. Investors should watch the upcoming earnings report — expected around July 31, 2026 — for management's commentary on contract pricing and Westinghouse milestones. The road to $100 looks passable, but it runs through a landscape that demands patience and conviction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.